title: Tacrolimus exposure after liver transplantation in randomized controlled trials: too much for too long.
authors.forename: M
authors.initials: M
authors.lastname: Rodríguez-Perálvarez
authors.forename: G
authors.initials: G
authors.lastname: Germani
authors.forename: T
authors.initials: T
authors.lastname: Darius
authors.forename: J
authors.initials: J
authors.lastname: Lerut
authors.forename: E
authors.initials: E
authors.lastname: Tsochatzis
authors.forename: M
authors.initials: M
authors.lastname: De la Mata
authors.forename: A K
authors.initials: AK
authors.lastname: Burroughs
mesh_terms: D004305:Dose-Response Relationship, Drug; D005919:Glomerular Filtration Rate / Q000187:drug effects; D006084:Graft Rejection / Q000517:prevention & control; D006085:Graft Survival / Q000187:drug effects*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects; D016031:Liver Transplantation; D016032:Randomized Controlled Trials as Topic; D051437:Renal Insufficiency / Q000139:chemically induced*; D016559:Tacrolimus / Q000008:administration & dosage / Q000009:adverse effects*
chemical_list: D007166:Immunosuppressive Agents; D016559:Tacrolimus